CytomX Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $78.5M | $104.6M |
| FY2017 | — | $69.9M | $177.5M |
| FY2018 | — | $135.8M | $247.6M |
| FY2019 | — | $25.5M | $188.4M |
| FY2020 | — | $-7.8M | $191.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $78.5M | $104.6M |
| FY2017 | — | $69.9M | $177.5M |
| FY2018 | — | $135.8M | $247.6M |
| FY2019 | — | $25.5M | $188.4M |
| FY2020 | — | $-7.8M | $191.9M |